ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,614.89
      1.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      05/31/20227:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      05/25/20228:00AMGlobeNewswire Inc.Aeterna Zentaris’ Licensing Partner, Consilient Health Announces European Launch of Ghryvelin™ (macimorelin) for Diagnosing Adult Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
      05/18/20228:00AMGlobeNewswire Inc.Aeterna Zentaris to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:AEZSAeterna Zentaris Inc
      05/17/20223:05PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      05/16/20222:15PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      05/16/20228:00AMGlobeNewswire Inc.Aeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share ConsolidationNASDAQ:AEZSAeterna Zentaris Inc
      05/13/20226:05AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AEZSAeterna Zentaris Inc
      05/12/20228:05AMGlobeNewswire Inc.Update on Positive Pre-Clinical Results from AIM Biologicals Development Program for the Potential Treatment of Parkinson’s DiseaseNASDAQ:AEZSAeterna Zentaris Inc
      05/11/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2022 Financial Results and Provides Business OutlookNASDAQ:AEZSAeterna Zentaris Inc
      05/11/20226:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      04/25/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Abstract Accepted for Presentation at IMMUNOLOGY2022™, the Annual Event of the American Association of ImmunologistsNASDAQ:AEZSAeterna Zentaris Inc
      04/20/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      04/19/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in AdultsNASDAQ:AEZSAeterna Zentaris Inc
      04/12/20228:05AMGlobeNewswire Inc.Aeterna Zentaris to Participate at the Virtual Investor 2022 CEO SpotlightNASDAQ:AEZSAeterna Zentaris Inc
      04/11/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on AutoimmunityNASDAQ:AEZSAeterna Zentaris Inc
      03/31/20224:11PMEdgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:AEZSAeterna Zentaris Inc
      03/29/20228:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      03/29/20228:00AMGlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business OutlookNASDAQ:AEZSAeterna Zentaris Inc
      03/29/20226:16AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AEZSAeterna Zentaris Inc
      03/29/20226:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      03/21/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
      03/11/20226:26AMTipRanksH.C. Wainwright Reiterates Their Buy Rating on Aeterna Zentaris (AEZS)NASDAQ:AEZSAeterna Zentaris Inc
      03/10/20227:05AMGlobeNewswire Inc.Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzburg Aiming to Accelerate Development of Vaccine ProgramsNASDAQ:AEZSAeterna Zentaris Inc
      03/02/20228:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      03/02/20228:05AMGlobeNewswire Inc.Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic HypoparathyroidismNASDAQ:AEZSAeterna Zentaris Inc
      02/11/20226:42AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AEZSAeterna Zentaris Inc
      02/07/20228:05AMGlobeNewswire Inc.Aeterna Zentaris to Present at the 2022 BIO CEO & Investor ConferenceNASDAQ:AEZSAeterna Zentaris Inc
      01/26/20224:29PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      01/26/20224:25PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      01/26/20224:05PMGlobeNewswire Inc.Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleNASDAQ:AEZSAeterna Zentaris Inc
       Showing the most relevant articles for your search:NASDAQ:AEZS

      Your Recent History

      BIT
      W83YE6
      UBS
      BIT
      3LAA
      Graniteshares 3x Long Al...
      Delayed Upgrade Clock